An International, Peer-Reviewed, Open Access Multidisciplinary Pharmacy Journal

A validated method for development of atovaquone as API and tablet dosage forms by UV spectroscopy

Submitted by webadmin on Fri, 10/14/2016 - 10:59
Pharmaceutical Methods,2010,1,1,61-64.
Published:October 2010
Type:Short Communication

A validated method for development of atovaquone as API and tablet dosage forms by UV spectroscopy

Kalpesh N Patel, Jayvadan K Patel, Manish P Patel, Ganesh C Rajput

Nootan Pharmacy College, Kamana Crossing, Visnagar - 384 315, India

Abstract:

A simple new spectrophotometric method has been developed for estimation of Atovaquone in bulk and tablet dosage form. Atovaquone is estimated to be 251 nm in methanol. The Beer’s law is obeyed in the concentration range of 1–10 μg/mL of the drug. The slope and intercept values are 0.111 and 0.012, respectively. Results of analysis of this method have been validated statically and by recovery studies. The method is applied to the marketed tablet formulation. A result of the analysis of tablet formulation, given as a percentage of label claim ± standard deviation, is 99.14 ± 0.66. The precision and accuracy has been examined by performing recovery studies and found to be 100.09 ± 1.14. The developed method is simple, sensitive, and reproducible, and can be used for the routine analysis of Atovaquone in bulk and tablet dosage form.

Calibration curve of atovaquone at 251 nm